chronic thromboembolic pulmonary hypertension


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.
Related to chronic thromboembolic pulmonary hypertension: Pulmonary thromboendarterectomy

chronic thromboembolic pulmonary hypertension

persistent pulmonary hypertension caused by obstruction of a major pulmonary artery by an unresolved embolus or multiple small pulmonary emboli.

chronic thromboembolic pulmonary hypertension

Abbreviation: CTEPH
Pulmonary HTN that results from the migration of blood clots (usually from the lower extremities) into the lungs. Elevated BP in the lungs gradually overloads the right ventricle and causes right-sided heart failure.

Symptoms

Symptoms usually include shortness of breath, esp. during exercise.

Treatment

The disease, when identified, may be treated with surgical removal of blood clots.

See also: hypertension
References in periodicals archive ?
Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension.
Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy.
Bosentan asa bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension.
Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF Chronic thromboembolic pulmonary hypertension.
Auger WR, Fedullo PF Chronic thromboembolic pulmonary hypertension.
Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension Study Group.
Adempas is indicated for the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), (WHO Group 4) after surgical treatment, or inoperable CTEPH, to improve exercise capacity and WHO functional class.
About Chronic Thromboembolic Pulmonary Hypertension (CTEPH) CTEPH is also a rare and life-threatening disease in which it is believed that thromboembolic occlusion (organized blood clots) of pulmonary vessels gradually lead to an increased pressure in the pulmonary arteries, resulting in an overload of the right heart.
Hemodynamic Assessment Of Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) In The Phase III CHEST-1 Study
About CHEST CHEST (Chronic Thromboembolic Pulmonary Hypertension sGC-Stimulator Trial) is a Phase III trial to assess the efficacy and safety of oral riociguat in the treatment of patients with either inoperable chronic thromboembolic pulmonary hypertension or pulmonary hypertension (PH) which has persisted or reoccurred after pulmonary endarterectomy (PEA).

Full browser ?